4 unknown. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 4 |
Follow Intervention group: new trials by email Literature Review of Intervention group trials Research Report on Intervention group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RCT Study of Levosimendan Improving Prognosis of Cardiac Arrest Levosimendan Injection, physiological saline - Heart Arrest | Phase 4 | Unknown | Peking University Third Hospital | 60 | 2023-08-01 | 2023-07-21 |
| Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD Bortezomib - Acute Lymphoblastic Leukemia, in Relapse, Chemotherapeutic Toxicity | Phase 4 | Unknown | Hospital General de Mexico | 56 | 2021-12-12 | 2022-01-18 |
| Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia Simvastatin - Strains, Acute Lymphoblastic Leukemia | Phase 4 | Unknown | Hospital General de Mexico | 108 | 2021-11-19 | 2022-01-04 |
| Prospective Randomized Trial On Radiation Dose Estimates Of CT Angiography In Patients Applying Iterative Image Reconstruction Techniques - The PROTECTION V Study - Control group, Intervention group - Coronary Artery Disease | Phase 4 | Unknown | Deutsches Herzzentrum Muenchen | 400 | 2011-10-01 | 2011-10-18 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Coronary Artery Disease (1) · Febrile Neutropenia (1) · Heart Arrest (1) · Neoplasm, Residual (1) · Recurrence (1) · Sepsis (1) · Sprains and Strains (1)
Hospital General de Mexico (2) · Deutsches Herzzentrum Muenchen (1) · Peking University Third Hospital (1)
Mexico (2) · Germany (1)
Adolfo Martinez Tovar, PhD (2) · Joerg Hausleiter, MD (1) · Ma Qingbian, doctor (1)